This inventor holds 5 USPTO granted patents. Top assignees: Kaneka Corporation, E-Tech Co., Ltd, Kanegafuchi Chemical Industry Co., Ltd.. Active years: 1992-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kobe, JP (1992)
- Hyogo, JP (1999 - 2017)
Company Filing History:


Years Active: 1992-2017
Title: Eiichi Yoshida: Innovator in Disinfectant Technology and Blood Treatment
Introduction
Eiichi Yoshida is a notable inventor based in Hyogo, Japan. He has made significant contributions to the fields of disinfectant technology and blood treatment, holding a total of 5 patents. His innovative approaches have the potential to impact public health and medical practices.
Latest Patents
Yoshida's latest patents include a volatile disinfectant and a method and apparatus for treating blood. The volatile disinfectant is produced by bubbling ozone gas into a volatile solvent, which contains at least one volatile liquid paraffin or silicone oil. This disinfectant effectively inactivates pathogens on surfaces and volatilizes after application. His method and apparatus for treating blood address pressure constraints during blood treatment, ensuring that pump flow rates can be adjusted to maintain optimal conditions without causing excessive pressure buildup.
Career Highlights
Throughout his career, Yoshida has worked with prominent companies such as Kaneka Corporation and Kanegafuchi Chemical Industry Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in health and safety.
Collaborations
Yoshida has collaborated with notable coworkers, including Takehisa Nakayama and Hiroshi Tachibana. Their combined expertise has fostered a creative environment that encourages innovation and problem-solving.
Conclusion
Eiichi Yoshida's contributions to disinfectant technology and blood treatment exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving safety and efficacy in medical practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile